Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

NCT: NCT01187368 · SUSPENDED

NCT IDNCT01187368
StatusSUSPENDED
Start Date2020-03-31
Completion2028-07-31

Brief Summary

This is a prospective, multi-center, unblinded, randomized, controlled, and non-inferiority study comparing the EVA2 LVAS to the most recent magnetically levitated centrifugal LVAS (HM3 LVAS).

Frequently Asked Questions

What is Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System?

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System is a clinical trial registered under NCT01187368. Current status: SUSPENDED.

What is the status of NCT01187368?

The current status of NCT01187368 (Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System) is: SUSPENDED.

When did Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System start?

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System started on 2020-03-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑